Glucose News and Research

RSS

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

24 May 2013

First Edition: May 22, 2013

Today's headlines include reports about how the Medicaid expansion is shaking out in Virginia and Texas, as well as a report about the role health care is playing as the House attempts to negotiate an immigration reform measure.

22 May 2013

ADA Education Recognition program recertifies Diabetes Resource Center at Sinai Hospital

The Diabetes Resource Center at Sinai Hospital of Baltimore has been awarded recertification by the American Diabetes Association Education Recognition program.

22 May 2013

Nearly 35% of Mexican young adults may have genetic predisposition for obesity, says U of I scientist

As many as 35 percent of Mexican young adults may have a genetic predisposition for obesity, said a University of Illinois scientist who conducted a study at the Universidad Aut-noma de San Luis Potosί.

22 May 2013

Clinical trial of Echo Therapeutics' Symphony CGM System receives IRB approval

Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, announced today that the Company's clinical trial of its Symphony CGM System has received Institutional Review Board approval.

21 May 2013

Study shows treatment of sleep apnea in patients with prediabetes improves blood sugar levels

Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in Philadelphia.

20 May 2013

Targeting glucagon action: A new frontier for regulating diabetes

For the first time, scientists at the Toronto General Research Institute showed that targeting glucagon action in the brain may be a new frontier for regulating diabetes.

20 May 2013

Newer class of diabetes medications may also improve cardiovascular health, researchers report

A newer class of medications used to control blood sugar levels in type 2 diabetics may also improve cardiovascular health, researchers from The Ohio State University Wexner Medical Center reported in a new meta-analysis presented yesterday at the American Society of Hypertension's Annual Scientific Meeting and Exposition.

17 May 2013

Injectable nanogel can monitor blood-sugar levels, secrete insulin when needed

Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin.

17 May 2013

People suffering from PTSD have risk of developing type 2 diabetes

The presence of posttraumatic stress disorder is significantly associated with the development of type 2 diabetes. This is the finding of scientists from the Helmholtz Zentrum München and the University Hospital Gieβen and Marburg who worked with data from the population-based KORA cohort study.

16 May 2013

Statistics reveal that about 79 million adult Americans walk around with prediabetes

Diabetes is one of the most misunderstood medical conditions. "It's not just about sugar. It's about your heart," says Nancy Ryan, RD, BC-ADM, a registered dietitian, board-certified in advanced diabetes management at Greenwich Hospital in Greenwich, Connecticut.

16 May 2013

Researchers see potential in deploying Akkermansia bacteria to understand and treat obesity

A dominant and useful bacterium called Akkermansia muciniphila is present in the intestinal system of all humans, from babies to the elderly. This microorganism is found in the intestinal mucus layer that protects against intruders.

16 May 2013

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and were less likely to be insulin resistant, even after excluding patients with a diagnosis of diabetes mellitus. Their findings are reported in the current issue of The American Journal of Medicine.

15 May 2013

Exercise is good for us - no matter what our age

The red double-decker buses that are symbolic of the city of London have an altogether different significance if you study heart disease. Sixty years ago, these iconic buses helped a Scottish medical doctor named Jerry Morris discover the link between physical activity and heart attacks.

15 May 2013

Telcare receives CE Mark approval to market mHealth glucose meter in the European Union

Telcare, Inc., the leader in mobile diabetes management solutions, today announced it has received CE Mark approval to market its cellular-enabled blood glucose meter, the first FDA-cleared mHealth glucose meter, in the European Union.

13 May 2013

Study: Metformin may not improve survival rates after breast cancer

Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new, first-of-its-kind study from Women's College Hospital has found the drug may not actually improve survival rates after breast cancer in certain patients.

10 May 2013

Echo Therapeutics reports net loss of $7.0 million for first quarter 2013

Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, today announced financial results for the quarter ended March 31, 2013.

10 May 2013

Lexicon Pharmaceuticals advances Phase 2 clinical trial of LX4211 in patients with type 1 diabetes

Lexicon Pharmaceuticals, Inc. announced today that it is progressing into the placebo-controlled portion of its Phase 2 clinical trial of LX4211 in patients with type 1 diabetes, having successfully completed the open-label, pioneer portion of the trial.

10 May 2013

Newly engineered biomaterials could lead to possible cure for Type 1 diabetes, find researchers

Researchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans.

10 May 2013

Abbott receives CE Mark for ARCHITECT HbA1c test

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.

9 May 2013

Glucose News and Research

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

First Edition: May 22, 2013

ADA Education Recognition program recertifies Diabetes Resource Center at Sinai Hospital

Nearly 35% of Mexican young adults may have genetic predisposition for obesity, says U of I scientist

Clinical trial of Echo Therapeutics' Symphony CGM System receives IRB approval

Study shows treatment of sleep apnea in patients with prediabetes improves blood sugar levels

Targeting glucagon action: A new frontier for regulating diabetes

Newer class of diabetes medications may also improve cardiovascular health, researchers report

Injectable nanogel can monitor blood-sugar levels, secrete insulin when needed

People suffering from PTSD have risk of developing type 2 diabetes

Statistics reveal that about 79 million adult Americans walk around with prediabetes

Researchers see potential in deploying Akkermansia bacteria to understand and treat obesity

Regular marijuana use is associated with favorable indices related to diabetic control, say investigators

Exercise is good for us - no matter what our age

Telcare receives CE Mark approval to market mHealth glucose meter in the European Union

Study: Metformin may not improve survival rates after breast cancer

Echo Therapeutics reports net loss of $7.0 million for first quarter 2013

Lexicon Pharmaceuticals advances Phase 2 clinical trial of LX4211 in patients with type 1 diabetes

Newly engineered biomaterials could lead to possible cure for Type 1 diabetes, find researchers

Abbott receives CE Mark for ARCHITECT HbA1c test

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News